Afficher la notice abrégée

dc.contributor.authorDobaño, Carlota
dc.contributor.authorRequena, Pilar
dc.date.accessioned2020-11-10T12:28:05Z
dc.date.available2020-11-10T12:28:05Z
dc.date.issued2020
dc.identifier.citationDobaño C, Bardají A, Arévalo-Herrera M, Martínez-Espinosa FE, Bôtto-Menezes C, Padilla N, et al. (2020) Cytokine signatures of Plasmodium vivax infection during pregnancy and delivery outcomes. PLoS Negl Trop Dis 14(5): e0008155. [https://doi.org/10.1371/journal.pntd.0008155]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/64175
dc.description.abstractPlasmodium vivax malaria is a neglected disease, particularly during pregnancy. Severe vivax malaria is associated with inflammatory responses but in pregnancy immune alterations make it uncertain as to what cytokine signatures predominate, and how the type and quantity of blood immune mediators influence delivery outcomes. We measured the plasma concentrations of a set of thirty-one biomarkers, comprising cytokines, chemokines and growth factors, in 987 plasma samples from a cohort of 572 pregnant women from five malaria-endemic tropical countries and related these concentrations to delivery outcomes (birth weight and hemoglobin levels) and malaria infection. Samples were collected at recruitment (first antenatal visit) and at delivery (periphery, cord and placenta). At recruitment, we found that P. vivax–infected pregnant women had higher plasma concentrations of proinflammatory (IL-6, IL-1β, CCL4, CCL2, CXCL10) and TH1-related cytokines (mainly IL-12) than uninfected women. This biomarker signature was essentially lost at delivery and was not associated with birth weight nor hemoglobin levels. Antiinflammatory cytokines (IL10) were positively associated with infection and poor delivery outcomes. CCL11 was the only biomarker to show a negative association with P. vivax infection and its concentration at recruitment was positively associated with hemoglobin levels at delivery. Birth weight was negatively associated with peripheral IL-4 levels at delivery. Our multi-biomarker multicenter study is the first comprehensive one to characterize the immunological signature of P. vivax infection in pregnancy thus far. In conclusion, data show that while TH1 and pro-inflammatory responses are dominant during P. vivax infection in pregnancy, antiinflammatory cytokines may compensate excessive inflammation avoiding poor delivery outcomes, and skewness toward a TH2 response may trigger worse delivery outcomes. CCL11, a chemokine largely neglected in the field of malaria, emerges as an important marker of exposure or mediator in this condition.es_ES
dc.description.sponsorshipEuropean Union Seventh Framework Programme (FP7/2007-2013) 201588es_ES
dc.description.sponsorshipMinisterio de Economia y Competitividad (National R&D Internationalization Programme, EUROSALUD 2008, Spain) EUS2009-03560es_ES
dc.description.sponsorshipCenters for Disease Control and Prevention (CDC) Foundationes_ES
dc.description.sponsorshipMalaria in Pregnancy Consortium (MiPc) - Bill & Melinda Gates Foundation 46099es_ES
dc.description.sponsorshipMiPces_ES
dc.description.sponsorshipSpanish Government RYC-2008-02631es_ES
dc.description.sponsorshipNational Health and Medical Research Council of Australia GNT1043345es_ES
dc.language.isoenges_ES
dc.publisherPUBLIC LIBRARY SCIENCEes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.titleCytokine signatures of Plasmodium vivax infection during pregnancy and delivery outcomeses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1371/journal.pntd.0008155


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Atribución 3.0 España
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución 3.0 España